Mayne Pharma Group Limited (OTCMKTS:MAYNF – Get Free Report) shares shot up 5.3% during mid-day trading on Friday . The stock traded as high as $2.00 and last traded at $2.00. Approximately 12,600 shares traded hands during trading, an increase of 264% from the average session volume of 3,463 shares. The stock had previously closed at $1.90.
Mayne Pharma Group Stock Performance
The business’s fifty day moving average price is $1.75 and its 200-day moving average price is $1.78.
Mayne Pharma Group Company Profile
Mayne Pharma Group (OTCMKTS:MAYNF) is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of prescription products. The company’s portfolio spans oral, transdermal and topical dosage forms, with a particular emphasis on women’s health, dermatology, pain management and other niche therapeutic areas. Through both branded and generic offerings, Mayne Pharma seeks to address unmet patient needs and provide cost-effective alternatives to established treatments.
In its development operations, Mayne Pharma leverages a combination of in-house research and external partnerships to advance product candidates through regulatory review.
See Also
- Five stocks we like better than Mayne Pharma Group
- Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector
- Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
- Apple’s Record Quarter Could Not Outrun Its Guidance Problem
- McKesson’s Compounding Keeps Adding Up
Receive News & Ratings for Mayne Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mayne Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.
